Department of Medicine

October 3, 2019

Diabetes drug study explores cardiovascular risks for patients with kidney disease

An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.

By Paul Govern
Adriana Hung, MD, MPH, talks with patient Sylvester Norman, who is participating in the VA Department’s Million Veteran Program.
September 25, 2019

Study shines light on architecture of kidney disease

A study of 280,000 U.S. veterans, including 56,000 African Americans, has identified in greater detail than ever before the genetic architecture of kidney function and chronic kidney disease (CKD), according to researchers at Vanderbilt University Medical Center and their colleagues.

By Bill Snyder
The study team included, from left, Douglas Johnson, MD, Dan Roden, MD, Javid Moslehi, MD, Joe-Elie Salem, MD, PhD, and Ali Manouchehri, MD.
September 25, 2019

Study identifies targeted therapy’s cardiac risks

After a recent study showed that chronic lymphocytic leukemia patients who received ibrutinib as a frontline treatment had a 7% death rate, a new study offers a clearer picture on the reasons for the deaths.

By Tom Wilemon
September 24, 2019

Treating C. diff: new purpose for an old drug?

An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice.

By Paul Govern
September 19, 2019

Gamazon receives NIH Genomic Innovator Award

VUMC’s Eric Gamazon is one of only six investigators to receive an inaugural Genomic Innovator Award from the National Human Genome Research Institute, part of the NIH.

By Leigh MacMillan
September 19, 2019

Study shows heat therapy helps ease supine hypertension

Heat therapy has been shown to lower high blood pressure in patients with a rare condition called supine hypertension, or elevated blood pressure when lying down, according to preliminary results of a Vanderbilt study.

By Matt Batcheldor
September 19, 2019

Potential prostate cancer biomarkers

An analysis of more than 140,000 people of European ancestry has identified blood protein biomarkers associated with prostate cancer risk.
By Leigh MacMillan
September 19, 2019

All-in-one pill helps reduce blood pressure, cholesterol

A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study.
By Craig Boerner
September 12, 2019

Vanderbilt’s Brown named dean of Yale School of Medicine

Nancy Brown, MD, Hugh J. Morgan Professor and chair of the Department of Medicine in the Vanderbilt University School of Medicine, has been named dean of the Yale School of Medicine. She will join Yale on Feb. 1, 2020.
By John Howser
September 12, 2019

ECMO program expanding to more intensive care units

VUMC is expanding its ECMO program from its longtime home in the Cardiovascular Intensive Care Unit (CVICU) to the Medical (MICU) and Trauma Intensive Care units.
By Matt Batcheldor
September 5, 2019

How salt increases blood pressure

Vanderbilt researchers have discovered that a protein called SGK1 in immune cells is activated by sodium, leading to the development of salt-sensitive hypertension.
By Leigh MacMillan
September 5, 2019

Study backs genetic testing for all metastatic breast cancer patients

By Tom Wilemon
September 4, 2019

Novel treatment for Prader-Willi syndrome being tested at VUMC

A novel treatment for Prader-Willi syndrome, one of the most common genetic causes of obesity, may improve the insatiable hunger that patients with the disorder experience.
By Leigh MacMillan
1 … 62 63 64 65 66 … 114